Global Trastuzumab Biosimilar Supply, Demand and Key Producers, 2023-2029

Page: 111

Published Date: 13 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Trastuzumab Biosimilar market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Trastuzumab is a monoclonal antibody that interferes with the human epidermal growth factor receptor 2 (HER2)/neu receptor.

This report studies the global Trastuzumab Biosimilar production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Trastuzumab Biosimilar, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Trastuzumab Biosimilar that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Trastuzumab Biosimilar total production and demand, 2018-2029, (K Units)
Global Trastuzumab Biosimilar total production value, 2018-2029, (USD Million)
Global Trastuzumab Biosimilar production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Trastuzumab Biosimilar consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Trastuzumab Biosimilar domestic production, consumption, key domestic manufacturers and share
Global Trastuzumab Biosimilar production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Trastuzumab Biosimilar production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Trastuzumab Biosimilar production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Trastuzumab Biosimilar market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen Inc., Pfizer Inc, Samsung Bioepis, Merck & Co., Biocon Limited, Teva Pharmaceutical, Genentech, Mundipharma and Celltrion, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Trastuzumab Biosimilar market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Trastuzumab Biosimilar Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Trastuzumab Biosimilar Market, Segmentation by Type
Adjuvant Breast Cancer
Metastatic Breast Cancer
Metastatic Gastric Cancer
Others

Global Trastuzumab Biosimilar Market, Segmentation by Application
Hospital Pharmacy
Online Pharmacy

Companies Profiled:
Amgen Inc.
Pfizer Inc
Samsung Bioepis
Merck & Co.
Biocon Limited
Teva Pharmaceutical
Genentech
Mundipharma
Celltrion
Henlius

Key Questions Answered
1. How big is the global Trastuzumab Biosimilar market?
2. What is the demand of the global Trastuzumab Biosimilar market?
3. What is the year over year growth of the global Trastuzumab Biosimilar market?
4. What is the production and production value of the global Trastuzumab Biosimilar market?
5. Who are the key producers in the global Trastuzumab Biosimilar market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Trastuzumab Biosimilar Introduction
    1.2 World Trastuzumab Biosimilar Supply & Forecast
        1.2.1 World Trastuzumab Biosimilar Production Value (2018 & 2022 & 2029)
        1.2.2 World Trastuzumab Biosimilar Production (2018-2029)
        1.2.3 World Trastuzumab Biosimilar Pricing Trends (2018-2029)
    1.3 World Trastuzumab Biosimilar Production by Region (Based on Production Site)
        1.3.1 World Trastuzumab Biosimilar Production Value by Region (2018-2029)
        1.3.2 World Trastuzumab Biosimilar Production by Region (2018-2029)
        1.3.3 World Trastuzumab Biosimilar Average Price by Region (2018-2029)
        1.3.4 North America Trastuzumab Biosimilar Production (2018-2029)
        1.3.5 Europe Trastuzumab Biosimilar Production (2018-2029)
        1.3.6 China Trastuzumab Biosimilar Production (2018-2029)
        1.3.7 Japan Trastuzumab Biosimilar Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Trastuzumab Biosimilar Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Trastuzumab Biosimilar Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Trastuzumab Biosimilar Demand (2018-2029)
    2.2 World Trastuzumab Biosimilar Consumption by Region
        2.2.1 World Trastuzumab Biosimilar Consumption by Region (2018-2023)
        2.2.2 World Trastuzumab Biosimilar Consumption Forecast by Region (2024-2029)
    2.3 United States Trastuzumab Biosimilar Consumption (2018-2029)
    2.4 China Trastuzumab Biosimilar Consumption (2018-2029)
    2.5 Europe Trastuzumab Biosimilar Consumption (2018-2029)
    2.6 Japan Trastuzumab Biosimilar Consumption (2018-2029)
    2.7 South Korea Trastuzumab Biosimilar Consumption (2018-2029)
    2.8 ASEAN Trastuzumab Biosimilar Consumption (2018-2029)
    2.9 India Trastuzumab Biosimilar Consumption (2018-2029)

3 World Trastuzumab Biosimilar Manufacturers Competitive Analysis
    3.1 World Trastuzumab Biosimilar Production Value by Manufacturer (2018-2023)
    3.2 World Trastuzumab Biosimilar Production by Manufacturer (2018-2023)
    3.3 World Trastuzumab Biosimilar Average Price by Manufacturer (2018-2023)
    3.4 Trastuzumab Biosimilar Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Trastuzumab Biosimilar Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Trastuzumab Biosimilar in 2022
        3.5.3 Global Concentration Ratios (CR8) for Trastuzumab Biosimilar in 2022
    3.6 Trastuzumab Biosimilar Market: Overall Company Footprint Analysis
        3.6.1 Trastuzumab Biosimilar Market: Region Footprint
        3.6.2 Trastuzumab Biosimilar Market: Company Product Type Footprint
        3.6.3 Trastuzumab Biosimilar Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Trastuzumab Biosimilar Production Value Comparison
        4.1.1 United States VS China: Trastuzumab Biosimilar Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Trastuzumab Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Trastuzumab Biosimilar Production Comparison
        4.2.1 United States VS China: Trastuzumab Biosimilar Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Trastuzumab Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Trastuzumab Biosimilar Consumption Comparison
        4.3.1 United States VS China: Trastuzumab Biosimilar Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Trastuzumab Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Trastuzumab Biosimilar Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Trastuzumab Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Trastuzumab Biosimilar Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Trastuzumab Biosimilar Production (2018-2023)
    4.5 China Based Trastuzumab Biosimilar Manufacturers and Market Share
        4.5.1 China Based Trastuzumab Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Trastuzumab Biosimilar Production Value (2018-2023)
        4.5.3 China Based Manufacturers Trastuzumab Biosimilar Production (2018-2023)
    4.6 Rest of World Based Trastuzumab Biosimilar Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Trastuzumab Biosimilar Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Trastuzumab Biosimilar Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Trastuzumab Biosimilar Production (2018-2023)

5 Market Analysis by Type
    5.1 World Trastuzumab Biosimilar Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Adjuvant Breast Cancer
        5.2.2 Metastatic Breast Cancer
        5.2.3 Metastatic Gastric Cancer
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World Trastuzumab Biosimilar Production by Type (2018-2029)
        5.3.2 World Trastuzumab Biosimilar Production Value by Type (2018-2029)
        5.3.3 World Trastuzumab Biosimilar Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Trastuzumab Biosimilar Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital Pharmacy
        6.2.2 Online Pharmacy
    6.3 Market Segment by Application
        6.3.1 World Trastuzumab Biosimilar Production by Application (2018-2029)
        6.3.2 World Trastuzumab Biosimilar Production Value by Application (2018-2029)
        6.3.3 World Trastuzumab Biosimilar Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Amgen Inc.
        7.1.1 Amgen Inc. Details
        7.1.2 Amgen Inc. Major Business
        7.1.3 Amgen Inc. Trastuzumab Biosimilar Product and Services
        7.1.4 Amgen Inc. Trastuzumab Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Amgen Inc. Recent Developments/Updates
        7.1.6 Amgen Inc. Competitive Strengths & Weaknesses
    7.2 Pfizer Inc
        7.2.1 Pfizer Inc Details
        7.2.2 Pfizer Inc Major Business
        7.2.3 Pfizer Inc Trastuzumab Biosimilar Product and Services
        7.2.4 Pfizer Inc Trastuzumab Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Pfizer Inc Recent Developments/Updates
        7.2.6 Pfizer Inc Competitive Strengths & Weaknesses
    7.3 Samsung Bioepis
        7.3.1 Samsung Bioepis Details
        7.3.2 Samsung Bioepis Major Business
        7.3.3 Samsung Bioepis Trastuzumab Biosimilar Product and Services
        7.3.4 Samsung Bioepis Trastuzumab Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Samsung Bioepis Recent Developments/Updates
        7.3.6 Samsung Bioepis Competitive Strengths & Weaknesses
    7.4 Merck & Co.
        7.4.1 Merck & Co. Details
        7.4.2 Merck & Co. Major Business
        7.4.3 Merck & Co. Trastuzumab Biosimilar Product and Services
        7.4.4 Merck & Co. Trastuzumab Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Merck & Co. Recent Developments/Updates
        7.4.6 Merck & Co. Competitive Strengths & Weaknesses
    7.5 Biocon Limited
        7.5.1 Biocon Limited Details
        7.5.2 Biocon Limited Major Business
        7.5.3 Biocon Limited Trastuzumab Biosimilar Product and Services
        7.5.4 Biocon Limited Trastuzumab Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Biocon Limited Recent Developments/Updates
        7.5.6 Biocon Limited Competitive Strengths & Weaknesses
    7.6 Teva Pharmaceutical
        7.6.1 Teva Pharmaceutical Details
        7.6.2 Teva Pharmaceutical Major Business
        7.6.3 Teva Pharmaceutical Trastuzumab Biosimilar Product and Services
        7.6.4 Teva Pharmaceutical Trastuzumab Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Teva Pharmaceutical Recent Developments/Updates
        7.6.6 Teva Pharmaceutical Competitive Strengths & Weaknesses
    7.7 Genentech
        7.7.1 Genentech Details
        7.7.2 Genentech Major Business
        7.7.3 Genentech Trastuzumab Biosimilar Product and Services
        7.7.4 Genentech Trastuzumab Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Genentech Recent Developments/Updates
        7.7.6 Genentech Competitive Strengths & Weaknesses
    7.8 Mundipharma
        7.8.1 Mundipharma Details
        7.8.2 Mundipharma Major Business
        7.8.3 Mundipharma Trastuzumab Biosimilar Product and Services
        7.8.4 Mundipharma Trastuzumab Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Mundipharma Recent Developments/Updates
        7.8.6 Mundipharma Competitive Strengths & Weaknesses
    7.9 Celltrion
        7.9.1 Celltrion Details
        7.9.2 Celltrion Major Business
        7.9.3 Celltrion Trastuzumab Biosimilar Product and Services
        7.9.4 Celltrion Trastuzumab Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Celltrion Recent Developments/Updates
        7.9.6 Celltrion Competitive Strengths & Weaknesses
    7.10 Henlius
        7.10.1 Henlius Details
        7.10.2 Henlius Major Business
        7.10.3 Henlius Trastuzumab Biosimilar Product and Services
        7.10.4 Henlius Trastuzumab Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Henlius Recent Developments/Updates
        7.10.6 Henlius Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Trastuzumab Biosimilar Industry Chain
    8.2 Trastuzumab Biosimilar Upstream Analysis
        8.2.1 Trastuzumab Biosimilar Core Raw Materials
        8.2.2 Main Manufacturers of Trastuzumab Biosimilar Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Trastuzumab Biosimilar Production Mode
    8.6 Trastuzumab Biosimilar Procurement Model
    8.7 Trastuzumab Biosimilar Industry Sales Model and Sales Channels
        8.7.1 Trastuzumab Biosimilar Sales Model
        8.7.2 Trastuzumab Biosimilar Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Trastuzumab Biosimilar Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Trastuzumab Biosimilar Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Trastuzumab Biosimilar Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Trastuzumab Biosimilar Production Value Market Share by Region (2018-2023)
    Table 5. World Trastuzumab Biosimilar Production Value Market Share by Region (2024-2029)
    Table 6. World Trastuzumab Biosimilar Production by Region (2018-2023) & (K Units)
    Table 7. World Trastuzumab Biosimilar Production by Region (2024-2029) & (K Units)
    Table 8. World Trastuzumab Biosimilar Production Market Share by Region (2018-2023)
    Table 9. World Trastuzumab Biosimilar Production Market Share by Region (2024-2029)
    Table 10. World Trastuzumab Biosimilar Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Trastuzumab Biosimilar Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Trastuzumab Biosimilar Major Market Trends
    Table 13. World Trastuzumab Biosimilar Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Trastuzumab Biosimilar Consumption by Region (2018-2023) & (K Units)
    Table 15. World Trastuzumab Biosimilar Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Trastuzumab Biosimilar Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Trastuzumab Biosimilar Producers in 2022
    Table 18. World Trastuzumab Biosimilar Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Trastuzumab Biosimilar Producers in 2022
    Table 20. World Trastuzumab Biosimilar Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Trastuzumab Biosimilar Company Evaluation Quadrant
    Table 22. World Trastuzumab Biosimilar Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Trastuzumab Biosimilar Production Site of Key Manufacturer
    Table 24. Trastuzumab Biosimilar Market: Company Product Type Footprint
    Table 25. Trastuzumab Biosimilar Market: Company Product Application Footprint
    Table 26. Trastuzumab Biosimilar Competitive Factors
    Table 27. Trastuzumab Biosimilar New Entrant and Capacity Expansion Plans
    Table 28. Trastuzumab Biosimilar Mergers & Acquisitions Activity
    Table 29. United States VS China Trastuzumab Biosimilar Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Trastuzumab Biosimilar Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Trastuzumab Biosimilar Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Trastuzumab Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Trastuzumab Biosimilar Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Trastuzumab Biosimilar Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Trastuzumab Biosimilar Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Trastuzumab Biosimilar Production Market Share (2018-2023)
    Table 37. China Based Trastuzumab Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Trastuzumab Biosimilar Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Trastuzumab Biosimilar Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Trastuzumab Biosimilar Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Trastuzumab Biosimilar Production Market Share (2018-2023)
    Table 42. Rest of World Based Trastuzumab Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Trastuzumab Biosimilar Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Trastuzumab Biosimilar Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Trastuzumab Biosimilar Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Trastuzumab Biosimilar Production Market Share (2018-2023)
    Table 47. World Trastuzumab Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Trastuzumab Biosimilar Production by Type (2018-2023) & (K Units)
    Table 49. World Trastuzumab Biosimilar Production by Type (2024-2029) & (K Units)
    Table 50. World Trastuzumab Biosimilar Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Trastuzumab Biosimilar Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Trastuzumab Biosimilar Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Trastuzumab Biosimilar Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Trastuzumab Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Trastuzumab Biosimilar Production by Application (2018-2023) & (K Units)
    Table 56. World Trastuzumab Biosimilar Production by Application (2024-2029) & (K Units)
    Table 57. World Trastuzumab Biosimilar Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Trastuzumab Biosimilar Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Trastuzumab Biosimilar Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Trastuzumab Biosimilar Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Amgen Inc. Basic Information, Manufacturing Base and Competitors
    Table 62. Amgen Inc. Major Business
    Table 63. Amgen Inc. Trastuzumab Biosimilar Product and Services
    Table 64. Amgen Inc. Trastuzumab Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Amgen Inc. Recent Developments/Updates
    Table 66. Amgen Inc. Competitive Strengths & Weaknesses
    Table 67. Pfizer Inc Basic Information, Manufacturing Base and Competitors
    Table 68. Pfizer Inc Major Business
    Table 69. Pfizer Inc Trastuzumab Biosimilar Product and Services
    Table 70. Pfizer Inc Trastuzumab Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Pfizer Inc Recent Developments/Updates
    Table 72. Pfizer Inc Competitive Strengths & Weaknesses
    Table 73. Samsung Bioepis Basic Information, Manufacturing Base and Competitors
    Table 74. Samsung Bioepis Major Business
    Table 75. Samsung Bioepis Trastuzumab Biosimilar Product and Services
    Table 76. Samsung Bioepis Trastuzumab Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Samsung Bioepis Recent Developments/Updates
    Table 78. Samsung Bioepis Competitive Strengths & Weaknesses
    Table 79. Merck & Co. Basic Information, Manufacturing Base and Competitors
    Table 80. Merck & Co. Major Business
    Table 81. Merck & Co. Trastuzumab Biosimilar Product and Services
    Table 82. Merck & Co. Trastuzumab Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Merck & Co. Recent Developments/Updates
    Table 84. Merck & Co. Competitive Strengths & Weaknesses
    Table 85. Biocon Limited Basic Information, Manufacturing Base and Competitors
    Table 86. Biocon Limited Major Business
    Table 87. Biocon Limited Trastuzumab Biosimilar Product and Services
    Table 88. Biocon Limited Trastuzumab Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Biocon Limited Recent Developments/Updates
    Table 90. Biocon Limited Competitive Strengths & Weaknesses
    Table 91. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 92. Teva Pharmaceutical Major Business
    Table 93. Teva Pharmaceutical Trastuzumab Biosimilar Product and Services
    Table 94. Teva Pharmaceutical Trastuzumab Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Teva Pharmaceutical Recent Developments/Updates
    Table 96. Teva Pharmaceutical Competitive Strengths & Weaknesses
    Table 97. Genentech Basic Information, Manufacturing Base and Competitors
    Table 98. Genentech Major Business
    Table 99. Genentech Trastuzumab Biosimilar Product and Services
    Table 100. Genentech Trastuzumab Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Genentech Recent Developments/Updates
    Table 102. Genentech Competitive Strengths & Weaknesses
    Table 103. Mundipharma Basic Information, Manufacturing Base and Competitors
    Table 104. Mundipharma Major Business
    Table 105. Mundipharma Trastuzumab Biosimilar Product and Services
    Table 106. Mundipharma Trastuzumab Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Mundipharma Recent Developments/Updates
    Table 108. Mundipharma Competitive Strengths & Weaknesses
    Table 109. Celltrion Basic Information, Manufacturing Base and Competitors
    Table 110. Celltrion Major Business
    Table 111. Celltrion Trastuzumab Biosimilar Product and Services
    Table 112. Celltrion Trastuzumab Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Celltrion Recent Developments/Updates
    Table 114. Henlius Basic Information, Manufacturing Base and Competitors
    Table 115. Henlius Major Business
    Table 116. Henlius Trastuzumab Biosimilar Product and Services
    Table 117. Henlius Trastuzumab Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 118. Global Key Players of Trastuzumab Biosimilar Upstream (Raw Materials)
    Table 119. Trastuzumab Biosimilar Typical Customers
    Table 120. Trastuzumab Biosimilar Typical Distributors
List of Figure
    Figure 1. Trastuzumab Biosimilar Picture
    Figure 2. World Trastuzumab Biosimilar Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Trastuzumab Biosimilar Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Trastuzumab Biosimilar Production (2018-2029) & (K Units)
    Figure 5. World Trastuzumab Biosimilar Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Trastuzumab Biosimilar Production Value Market Share by Region (2018-2029)
    Figure 7. World Trastuzumab Biosimilar Production Market Share by Region (2018-2029)
    Figure 8. North America Trastuzumab Biosimilar Production (2018-2029) & (K Units)
    Figure 9. Europe Trastuzumab Biosimilar Production (2018-2029) & (K Units)
    Figure 10. China Trastuzumab Biosimilar Production (2018-2029) & (K Units)
    Figure 11. Japan Trastuzumab Biosimilar Production (2018-2029) & (K Units)
    Figure 12. Trastuzumab Biosimilar Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Trastuzumab Biosimilar Consumption (2018-2029) & (K Units)
    Figure 15. World Trastuzumab Biosimilar Consumption Market Share by Region (2018-2029)
    Figure 16. United States Trastuzumab Biosimilar Consumption (2018-2029) & (K Units)
    Figure 17. China Trastuzumab Biosimilar Consumption (2018-2029) & (K Units)
    Figure 18. Europe Trastuzumab Biosimilar Consumption (2018-2029) & (K Units)
    Figure 19. Japan Trastuzumab Biosimilar Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Trastuzumab Biosimilar Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Trastuzumab Biosimilar Consumption (2018-2029) & (K Units)
    Figure 22. India Trastuzumab Biosimilar Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Trastuzumab Biosimilar by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Trastuzumab Biosimilar Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Trastuzumab Biosimilar Markets in 2022
    Figure 26. United States VS China: Trastuzumab Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Trastuzumab Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Trastuzumab Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Trastuzumab Biosimilar Production Market Share 2022
    Figure 30. China Based Manufacturers Trastuzumab Biosimilar Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Trastuzumab Biosimilar Production Market Share 2022
    Figure 32. World Trastuzumab Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Trastuzumab Biosimilar Production Value Market Share by Type in 2022
    Figure 34. Adjuvant Breast Cancer
    Figure 35. Metastatic Breast Cancer
    Figure 36. Metastatic Gastric Cancer
    Figure 37. Others
    Figure 38. World Trastuzumab Biosimilar Production Market Share by Type (2018-2029)
    Figure 39. World Trastuzumab Biosimilar Production Value Market Share by Type (2018-2029)
    Figure 40. World Trastuzumab Biosimilar Average Price by Type (2018-2029) & (US$/Unit)
    Figure 41. World Trastuzumab Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 42. World Trastuzumab Biosimilar Production Value Market Share by Application in 2022
    Figure 43. Hospital Pharmacy
    Figure 44. Online Pharmacy
    Figure 45. World Trastuzumab Biosimilar Production Market Share by Application (2018-2029)
    Figure 46. World Trastuzumab Biosimilar Production Value Market Share by Application (2018-2029)
    Figure 47. World Trastuzumab Biosimilar Average Price by Application (2018-2029) & (US$/Unit)
    Figure 48. Trastuzumab Biosimilar Industry Chain
    Figure 49. Trastuzumab Biosimilar Procurement Model
    Figure 50. Trastuzumab Biosimilar Sales Model
    Figure 51. Trastuzumab Biosimilar Sales Channels, Direct Sales, and Distribution
    Figure 52. Methodology
    Figure 53. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Trastuzumab Biosimilar Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Trastuzumab Biosimilar Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 29 Jan 2021

date Pharma & Healthcare

The Trastuzumab Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Trastuzumab Biosimilar Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Trastuzumab Biosimilar Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 09 Jan 2022

date Pharma & Healthcare

Global Trastuzumab Biosimilar Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Trastuzumab Biosimilar Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 04 Jan 2023

date Pharma & Healthcare

Trastuzumab is a monoclonal antibody that interferes with the human epidermal growth factor receptor 2 (HER2)/neu receptor.

Global Trastuzumab Biosimilar Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Trastuzumab Biosimilar Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 15 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Trastuzumab Biosimilar market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

trastuzumab biosimilar

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>